10/27, 2:53 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Novavax

Novavax files for UK COVID vaccine approval

Novavax Inc, announced on Wednesday that it has applied to the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) for authorization of its COVID-19 vaccine NVX-CoV2373.

"This submission brings Novavax significantly closer to delivering millions of doses of the first protein-based COVID-19 vaccine, built on a proven, well-understood vaccine platform that demonstrated high efficacy against multiple strains of the coronavirus," declared the company's President and CEO Stanley C. Erck.

The firm has previously submitted results from a phase 3 clinical trial of 15,000 volunteers in the UK that demonstrated 89.7% efficacy against all strains, as well as a "favorable safety and tolerability profile."

Breaking the News / IB